Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum

Vaccine
S PichyangkulDouglas S Walsh

Abstract

We compared the safety and immunogenicity of the recombinant Plasmodium falciparum MSP1(42) antigen formulated with four novel adjuvant systems (AS01B, AS02A, AS05 and AS08) to alum in rhesus monkeys. All five formulations of MSP1(42) were safe and immunogenic. Whereas, all MSP1(42) formulations tested generated high stimulation indices for lymphocyte proliferation (ranging from 27 to 50), the AS02A and AS01B formulations induced the highest levels of specific anti-MSP1(42) antibody. ELISPOT assays showed that the AS02A and AS01B vaccine formulations-induced different cytokine response profiles. Using the ratio of IFN-gamma/IL-5 secreting cells as the metric, the AS01B formulation induced a strong Th1 response, whereas the AS02A formulation induced a balanced Th1/Th2 response. The IFN-gamma response generated by AS02A and AS01B formulations persisted at least 24 weeks after final vaccination. The notable difference in Th1/Th2 polarization induced by the AS02A and AS01B formulations warrants comparative clinical testing.

References

May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·W A SiddiquiS C Kan
Nov 13, 1984·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A A Holder, R R Freeman
Jul 1, 1994·The Journal of Experimental Medicine·M J BlackmanA A Holder
Nov 1, 1993·Molecular and Biochemical Parasitology·M J BlackmanA A Holder
Nov 7, 1998·The Journal of Infectious Diseases·J A StouteW R Ballou
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·C L Brazolot MillanH L Davis
Oct 20, 1999·Methods : a Companion to Methods in Enzymology·J R Baldridge, R T Crane
Jul 19, 2000·Current Opinion in Immunology·V E Schijns
Feb 15, 2001·The Journal of Infectious Diseases·K E KesterUNKNOWN RTS,S Malaria Vaccine Evaluation Group
Mar 10, 2001·Nature·R L ReinhardtM K Jenkins
May 4, 2001·Journal of Immunological Methods·S PichyangkulD G Heppner
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·Anthony W StowersLouis H Miller
Sep 5, 2002·Medicinal Research Reviews·Lyann M B Ursos, Paul D Roepe
May 14, 2003·Molecular and Biochemical Parasitology·Evelina AngovJeffrey A Lyon
Jun 13, 2003·Pathologie-biologie·R M Steinman
Sep 9, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Charlotte Read KensilAlemseged Truneh
Oct 3, 2006·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·M Andreina PachecoAnanias A Escalante

❮ Previous
Next ❯

Citations

Jan 25, 2014·Malaria Journal·Mohamed Salem O Ahmedou SalemAli O Mohamed Salem O Boukhary
Jan 1, 2014·Vaccines·Deana N Toussi, Paola Massari
Jun 2, 2007·Proceedings of the National Academy of Sciences of the United States of America·Peng Fei ZhangGerald V Quinnan
Jan 1, 2014·Vaccines·Benoît LevastSylvia van Drunen Littel-van den Hurk
Nov 25, 2006·PLoS Clinical Trials·Mark R WithersUNKNOWN MSP-1 Malaria Vaccine Working Group
Aug 1, 2008·Cellular and Molecular Life Sciences : CMLS·C R Casella, T C Mitchell
Oct 28, 2010·Current Opinion in HIV and AIDS·Silvija I StapransDanilo R Casimiro
Feb 24, 2006·Nature Reviews. Immunology·Adrian V S Hill
May 1, 2008·Expert Review of Vaccines·Rajeev K TyagiAbhinav Mehta
Jul 28, 2013·Expert Review of Vaccines·Gregory C Ireton, Steven G Reed
Oct 13, 2007·Expert Review of Vaccines·Nathalie GarçonMarcelle Van Mechelen
Aug 9, 2005·Expert Opinion on Emerging Drugs·W Ripley Ballou
Jul 8, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Luis A Brito, Derek T O'Hagan
Dec 9, 2008·Trends in Immunology·Steven G ReedMartin Friede
Apr 26, 2007·The American Journal of Pathology·Dieudonnée TogbeBernhard Ryffel
Aug 21, 2009·Parasite Immunology·R N ColerS G Reed
Jun 24, 2015·Regulatory Toxicology and Pharmacology : RTP·Lawrence SegalNathalie Garçon
Jun 29, 2016·Clinical & Translational Immunology·Jennifer K Dowling, Ashley Mansell
Oct 19, 2006·Vaccine·Marc P GirardMarie Paule Kieny
Jul 31, 2004·New Directions for Child and Adolescent Development·Daisuke AkibaCynthia T García Coll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.